Move beyond static validation with lifecycle bioassay management

Wednesday, July 29 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT

Bioassays play a critical role in biologics development, supporting decisions across assay development, validation, CMC strategy, regulatory readiness, and long-term product lifecycle management. However, as biologics programs become more complex and regulatory expectations continue to evolve, traditional one-time validation approaches may no longer provide the flexibility or confidence required to maintain strong assay performance over time.

In this SelectScience^® webinar, Dr. Ryan Dorfman, Chief Operating Officer at Prolytix, will explore the industry shift toward lifecycle bioassay strategies and why organizations are moving beyond static validation as the endpoint.

Drawing on more than 25 years of experience across the biopharmaceutical, diagnostics, and analytical testing industries, Dorfman will discuss the ongoing challenges of one-time validation, how regulatory expectations are evolving, and what teams should consider when building a practical roadmap for lifecycle bioassay management.

Attend this webinar and gain insight into how lifecycle strategies can support stronger bioassays, improved regulatory readiness, and more consistent decision-making across biologics development programs.

Certificate of attendance

If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Webinar details

• Cost: Free to attend
• Location: Online
• Duration: 60 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.